Viewing Study NCT02134834


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-02-25 @ 3:01 AM
Study NCT ID: NCT02134834
Status: COMPLETED
Last Update Posted: 2014-12-12
First Post: 2014-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
Sponsor: Meiji Seika Pharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module